Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Bottles of a trial Covid-19 vaccine on a table in a lab in Brussels on June 18, 2020. (Photo: Vincent Kalut/Photonews via Getty Images)

Two Days After Pfizer's Hopeful Vaccine News, 82% of Doses Already Bought by World's Richest Nations

"You couldn't get a clearer example of how unequal the pharmaceutical system is—some make billions of pounds, while many others die because they cannot afford treatments or there are no more left for them to buy."

Julia Conley

Campaigners in the United Kingdom on Wednesday warned that just two days after pharmaceutical giant Pfizer shared positive early results of its coronavirus vaccine trial, mass purchases of the vaccine by the world's richest countries have left more than 85% of the global population—namely, the world's poorest—without any way to access it. 

Pfizer says it can produce 1.35 billion doses of the vaccine, which was shown according to Pfizer's first formal review to be 90% effective at preventing coronavirus infection in patients who have never had the virus, by the end of 2021. More than one billion of those doses—82% of the supply—have already been purchased by wealthy countries. 

The U.S. has purchased 100 million doses with an option to buy 500 million, enough to potentially immunize its entire population against the coronavirus with hundreds of millions of doses left over. Since Monday Pfizer has also sold 40 million doses to the U.K. and 200 million doses to the E.U., with an option to buy 100 million more. 

"Unless we break the stranglehold of these massive corporations over our medicines, the injustice will continue."
—Nick Dearden, Global Justice Now

In a statement, the British campaign group Global Justice Now noted that Pfizer's partner in the development of the vaccine, German manufacturer BioNTech, has received financing of €375 million ($441 million) from the German government and €100 million ($117 million) from the European Investment Bank.

"Pfizer claims not to have had any state support, but the advance purchase of a billion doses of an unproven drug, not to mention the tax breaks and direct public funding of Pfizer’s partner suggests their claim is misleading at best," said Global Justice Now director Nick Dearden. "Unless we break the stranglehold of these massive corporations over our medicines, the injustice will continue."

Global Justice Now noted that Pfizer is likely to give some doses to developing countries through the World Health Organization's Covid-19 Vaccines Global Access Facility (COVAX). However, those doses are expected to make up a small fraction of those produced by Pfizer, leaving billions of people without access to the vaccine. 

COVAX has been undermined by the refusal of some wealthy countries, including the U.S., to take part in the global effort to ensure vaccine access, and now by mass purchases by some of those same countries. 

"You couldn't get a clearer example of how unequal the pharmaceutical system is—some make billions of pounds, while many others die because they cannot afford treatments or there are no more left for them to buy," Dearden said. "It's got to change."

Global Justice Now repeated its call from earlier this week for the suspension of global patent rules to make it possible for poor countries to develop generic versions of Pfizer's vaccine. South Africa and India last month proposed that the World Trade Organization suspend the rules on intellectual property for vaccines and treatments related to Covid-19.

"It is imperative that we end the vaccine nationalism and that sufficient supply is made available to all, on a fair basis, as a matter of urgency," said Dearden. "That can be helped by supporting governments like South Africa and India who are trying to suspend intellectual property rules at the WTO during this global emergency."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

'Utterly Shameless': Former Democratic Senators Join Fossil Fuel Lobby Group

"This is climate denial and shameful bullshit," scoffed one scientist. "Also the future for Manchin and Sinema."

Brett Wilkins ·


'When You Don't Change People's Lives, People Get Upset,' Says AOC

To reverse slump in Democratic approval ratings, the congresswoman said Biden should start by cancelling student loan debt.

Julia Conley ·


Sioux Tribe Withdraws as Cooperating Agency Over Dakota Access Pipeline Threat

"The prospect of an oil spill during such low water is truly scary," says the tribe's Water Resources Department administrator.

Jessica Corbett ·


New Report Shows How US Transportation System 'Fuels Inequality'

Favoring cars over public transit has "consequences for racial and economic justice, the environment, and more," the Institute for Policy Studies warns.

Brett Wilkins ·


Gas Stoves Even Worse for Climate, Health Than Previously Thought

New study shows methane leaks from U.S. gas-burning stoves have a climate impact comparable to emissions from about 500,000 cars.

Jessica Corbett ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo